August 5, 2015
Par Pharmaceutical announced Wednesday that the Food and Drug Administration had granted final approval of the company’s generic version of Sodium Edecrin (ethacrynate sodium) for injection.
July 31, 2015

Bayer HealthCare Pharmaceuticals on Friday announced that the Food and Drug Administration approved the company’s Finacea (azelaic acid) Foam, 15% for the topical treatment rosacea.

July 23, 2015

A new coalition has formed to ensure safe access to over-the-counter pain relief remedies. The Protecting Access to Pain Relief Coalition officially launched on June 22 to help ensure that American consumers continue to have access to, and choice of, safe and effective pain relief, including acetaminophen.

June 24, 2015

Aurobindo Pharma Limited has announced that it has received final approval from the U.S. Food and Drug Administration for entacapone tablets USP, 200 mg, the generic equivalent to Comtan Tablets 200 mg.

June 2, 2015
Aurobindo Pharma Limited has received approval from the Food and Drug Administration for its generic equivalent to Flagyl (metronidazole) tablets in 250- and 500-mg dosage strengths.  
 
June 1, 2015

Teva announced Monday that it had launched its generic version of Actonel (risedronate sodium) in 5-, 30- and 35-mg dosage strengths. 

May 26, 2015

Aurobindo Pharma has submitted an abbreviated new drug application for dolutegravir 50 mg to the Food and Drug Administration for the treatment of HIV.

April 20, 2015

Aurobindo Pharmacy on Monday announced that it has received the first abbreviated new drug approval from the Food and Drug Administration for cefixime for oral suspension

March 13, 2015

An Alliance for Aging Research survey found that consumers want to maintain nonprescription access to acetaminophen. 

March 10, 2015

The Food and Drug Administration recently published bio-equivalence guidance documents. 

February 3, 2015

Zogenix last week announced that the Food and Drug Administration approved a new formulation of the company's Zohydro ER (hydrocodone bitartrate) extended-release capsules, CII.

January 30, 2015

Janssen Therapeutics on Thursday announced that the Food and Drug Administration has approved its Prezcobix (darunavir 800 mg/cobicistat 150 mg) tablets. The drug is used to treat human immunodeficiency virus in combination with other antiretovirals for treatment-naïve and treatment-experienced adults with no darunavir resistance-associated substitutions, according to the company.

 

January 26, 2015

Purdue Pharma on Monday announced the launch of Hysingla ER (hydrocodone bitartrate) extended-release tablets CII. According to the company, the once-daily drug is the first and only hydocodone product to be recognized by the Food and Drug Administration as having properties that deter misuse and abuse via chewing, snorting and injection.

January 14, 2015

The University of Florida's Pharm.D. program recently released an infographic around the risks associated with acetaminophen use. 

November 20, 2014

Purdue Pharma on Thursday announced that the Food and Drug Administration approved Hysingla ER (hydrocodone bitartrate) extended‐release tablets CII, a once‐daily, single‐entity medication formulated using Purdue’s proprietary extended‐release solid oral platform, Resistec.

October 28, 2014

The Acetaminophen Awareness Coalition on Tuesday kicked off its annual “Double Check; Don’t Double Up” campaign.

October 9, 2014

The Food and Drug Administration earlier this month issued draft guidance with several recommendations for manufacturers of acetaminophen products. 

October 8, 2014

Teva Pharmaceutical Industries on Wednesday announced the initiation of a rolling new drug application submission for hydrocodone bitartrate extended-release tablets.

October 1, 2014

Bayer on Wednesday announced it has completed the acquisition of the consumer care business of the U.S. pharmaceuticals group Merck.

 

September 5, 2014

Purdue Pharma on Thursday shared results from several studies evaluating its investigational pain medication Hysingla ER.

August 25, 2014

Pharmaceutical company Iroko announced today that a new version its anti-inflammatory drug Zorvolex had been approved by the Food and Drug Administration.

July 22, 2014

The Food and Drug Administration has granted tentative approval to Teva Pharmaceutical for abacavir sulfate and lamivudine tablets, according to agency records.

July 17, 2014

Purdue Pharma announced that the Food and Drug Administration approved a new 7.5-mcg/hour dosage strength of Butrans (buprenorphine) transdermal system CIII.

July 17, 2014

About 30% of top-performing OTC drugs today were once prescription-only medications noted Dave Wendland, VP Hamacher Resource Group, on Thursday during a videocast hosted by GMDC titled "Rx-to-OTC: Getting it Right at Retail."